JMP Securities Starts Summit Therapeutics plc (SMMT) at Market Outperform Nov 4, 2024 03:27AM
JMP Securities Downgrades Summit Therapeutics plc (SMMT) to Market Perform Jun 28, 2018 05:18AM
Summit Therapeutics to Present at the JMP Securities Life Sciences Conference Jun 15, 2018 07:00AM
Summit Therapeutics Announces Exercise of Underwriters’ Over-Allotment Option Sep 15, 2017 01:31PM
Summit Therapeutics plc (SMMT) Prices 1.46M ADS Offering at $12/Sh Sep 14, 2017 06:23AM


Sep 13, 2017 11:03PM Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares
Sep 13, 2017 04:36PM Summit Therapeutics (SMMT) Announces Offering of $15M of ADSs
Sep 13, 2017 04:35PM Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary Shares
Jun 15, 2017 07:00AM Summit Therapeutics to Participate in JMP Securities Life Sciences Conference
Jun 16, 2016 07:00AM Summit Therapeutics to Present at JMP Securities Life Sciences Conference
Dec 10, 2015 07:00AM Summit Therapeutics to Participate in the JMP Securities DMD Forum
Jun 15, 2015 07:00AM Summit to Present at JMP Securities Life Sciences Conference
Apr 2, 2015 06:47AM JMP Securities Starts Summit Therapeutics plc (SMMT) at Market Outperform, $32 PT
Mar 18, 2015 02:15PM Summit Therapeutics Announces Exercise of Over-Allotment Option
Mar 10, 2015 12:45PM Summit Therapeutics Announces Closing of Its U.S. Initial Public Offering
Mar 5, 2015 10:03AM Summit Therapeutics (SMMT) IPO Opens Fractionally Higher